QuantHealth secured $45 million in Series B funding to expand an AI platform that simulates clinical trials before patients enroll. The company aims to predict patient outcomes and improve trial design by running virtual studies that can identify likely endpoints and reduce the number of unsuccessful programs. QuantHealth’s stated goal is to cut into the industry’s high failure rate and accelerate timelines for effective drugs to reach the market. The platform is positioned as an augmentation for sponsors planning trial logistics and statistical assumptions. The financing also highlights how venture capital is continuing to fund computational approaches to clinical development, especially where faster decisions and improved probability-of-success can translate into material R&D savings.